← Browse by Condition
Medical Condition

oncology

Total Trials
11
Recruiting Now
11
Trial Phases
Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for oncology sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — oncology Clinical Trials

How many clinical trials are currently recruiting for oncology?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for oncology, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for oncology?
oncology research spans Phase 1 (1 trial), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a oncology clinical trial?
Eligibility criteria for oncology trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 3
2
Top Sponsors
National University of Ireland, Galway, Ireland 1 trial
GE Healthcare 1 trial
Sherief Abd-Elsalam 1 trial
Institut du Cancer de Montpellier - Val d'Aurelle 1 trial
Population Health Research Institute 1 trial

Recruiting Clinical Trials

NCT05921279
Recruiting
Understanding CARdiac Events in Breast Cancer
Enrollment
100 pts
Location
Ireland
Sponsor
National University of Ireland...
View Trial →
NCT05629689 Phase 1
Recruiting
A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies
Enrollment
50 pts
Location
Netherlands
Sponsor
GE Healthcare
View Trial →
NCT04217512 Phase 3
Recruiting
Pantoprazole in Cisplatin Nephrotoxicity
Enrollment
60 pts
Location
Egypt
Sponsor
Sherief Abd-Elsalam
View Trial →
NCT05197972
Recruiting
Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery
Enrollment
296 pts
Location
France
Sponsor
Institut du Cancer de Montpell...
View Trial →
NCT05738252
Recruiting
Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients
Enrollment
280 pts
Location
Canada
Sponsor
Population Health Research Ins...
View Trial →
NCT04900558
Recruiting
Robotic Radical Cystectomy Outcomes
Enrollment
500 pts
Location
Italy
Sponsor
University of Florence
View Trial →
NCT06558487
Recruiting
The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
Enrollment
200 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
View Trial →
NCT07532083
Recruiting
Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
Enrollment
2,000 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
View Trial →
NCT04726228
Recruiting
Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)
Enrollment
40 pts
Location
Italy
Sponsor
National Cancer Institute, Nap...
View Trial →
NCT07633236 Phase 3
Recruiting
Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy
Enrollment
100 pts
Location
Russia
Sponsor
Blokhin's Russian Cancer Resea...
View Trial →
NCT06317389
Recruiting
PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments
Enrollment
3,000 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →

Related Conditions

surgery (2) breast cancer (1) cardiotoxicity (1) cardiomyopathies (1) chemotherapeutic toxicity (1) heart failure (1) malignant solid tumor (1) gynecologic cancer (1) frailty (1) bladder cancer (1) muscle invasive bladder carcinoma (1) recurrence (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology